KSQ Therapeutics develops and deploys precision functional genomics to discover drug therapies. The Company has built a genome-scale precision functional genomics platform, called CRISPRomics, to pinpoint therapeutic nodes that directly correlate genomic function to disease with unprecedented certainty and speed.